Athenex, Inc.

Athenex, Inc.verified

ATNX

Price:

$0.2031

Market Cap:

$2.33M

Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in cutaneous angiosarcoma, advanced gastric cancer, and advanced solid malignancies. It also offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis. In addition, the comp...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-06-14

Stock Exchange

NASDAQ

Ticker

ATNX

The ROE as of December 2024 (TTM) for Athenex, Inc. (ATNX) is 21.51%

According to Athenex, Inc.’s latest financial reports and current stock price. The company's current ROE is 21.51%. This represents a change of 5.35% compared to the average of 20.42% of the last 4 quarters.

Athenex, Inc. (ATNX) Historical ROE (quarterly & annually)

How has ATNX ROE performed in the past?

The mean historical ROE of Athenex, Inc. over the last ten years is 106.50%. The current 21.51% ROE has changed -79.80% with respect to the historical average. Over the past ten years (40 quarters), ATNX's ROE was at its highest in in the December 2022 quarter at 442.19%. The ROE was at its lowest in in the June 2022 quarter at -201.37%.

Quarterly (TTM)
Annual

Average

106.50%

Median

-74.63%

Minimum

-259.46%

Maximum

1.52%

Athenex, Inc. (ATNX) ROE by Quarter and Year

Discovering the peaks and valleys of Athenex, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 7.05%

Maximum Annual ROE = 1.52%

Minimum Annual Increase = -125.75%

Minimum Annual ROE = -259.46%

Quarterly (TTM)
Annual
YearROEChange
20221.52%7.05%
202121.26%-125.75%
2020-82.57%23.80%
2019-66.69%-20.86%
2018-84.27%-42.15%
2017-145.68%-43.85%
2016-259.46%400.25%

Athenex, Inc. (ATNX) Average ROE

How has ATNX ROE performed in the past?

The current ROE of Athenex, Inc. (ATNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

486.66%

5-year avg

261.80%

10-year avg

106.50%

Athenex, Inc. (ATNX) ROE vs. Peers

How is ATNX’s ROE compared to its peers?

Athenex, Inc.’s ROE is less than G1 Therapeutics, Inc. (26.28%), greater than Adverum Biotechnologies, Inc. (-65.14%), less than AVROBIO, Inc. (29.68%), greater than CytomX Therapeutics, Inc. (-41.34%), greater than Rubius Therapeutics, Inc. (-238.11%),

Build a custom stock screener for Athenex, Inc. (ATNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Athenex, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Athenex, Inc. (ATNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Athenex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Athenex, Inc.'s ROE?

How is the ROE calculated for Athenex, Inc. (ATNX)?

What is the highest ROE for Athenex, Inc. (ATNX)?

What is the 3-year average ROE for Athenex, Inc. (ATNX)?

What is the 5-year average ROE for Athenex, Inc. (ATNX)?

How does the current ROE for Athenex, Inc. (ATNX) compare to its historical average?